Wogonin is a dihydroxy- and monomethoxy-flavone in which the hydroxy groups are positioned at C-5 and C-7 and the methoxy group is at C-8.
定义
Wogonin is a dihydroxy- and monomethoxy-flavone in which the hydroxy groups are positioned at C-5 and C-7 and the methoxy group is at C-8. It has a role as an antineoplastic agent, an angiogenesis inhibitor, a cyclooxygenase 2 inhibitor and a plant metabolite. It is a monomethoxyflavone and a dihydroxyflavone. It is a conjugate acid of a wogonin(1-).
来源: PubChem
美国FDA 物质登记 · UNII POK93PO28W · 登记名称 WOGONIN · 单一化学物质
化妆品中的作用
使头发或皮肤褪色BLEACHING
详细资料——标示名称、识别编号、物性、试验记录、文献
别名和识别信息
WOGONININCI
- CAS No.化学物质登记号
- 632-85-9
- DTXSID美国EPA化学品编号
- DTXSID70212557
- DTXCID美国EPA化合物编号
- DTXCID00135048
- IUPAC
- 5,7-Dihydroxy-8-methoxy-2-phenyl-4H-1-benzopyran-4-one
- 分子式
- C16H12O5
- 分子量
- 284.267 g/mol
产品实际使用的用途
相关文献
- Wogonin as a potential therapeutic agent for psoriasis: Core target identification and validation · 2026
- Wogonin ameliorates the proliferation, inflammatory response, and pyroptosis in keratinocytes via NOD‐like receptor family pyrin domain containing 3/Caspase‐1/Gasdermin‐D pathway · 2024
- Topical Application of Wogonin Provides a Novel Treatment of Knee Osteoarthritis · 2020
- Wogonin suppresses proliferation and invasion of skin epithelioid carcinoma cells through Notch1. · 2020
- Wogonin inhibits the proliferation and invasion, and induces the apoptosis of HepG2 and Bel7402 HCC cells through NF‑κB/Bcl-2, EGFR and EGFR downstream ERK/AKT signaling. · 2016